Concepedia

Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies

Melanie J. Davies, P Sinnassamy, F. Storms, Ramón Gomis

Diabetes Research and Clinical Practice · 2007 · 42 citations · 16 references

DOIFull text

Open access

Concepts

References

16

The Treat-to-Target Trial

Matthew C. Riddle, Julio Rosenstock, John Gerich · Diabetes Care · 2003 · 1.5K citations · Full text

, , +17

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Mauro Lepore, Simone Pampanelli, Carmine G. Fanelli et al. · Diabetes · 2000 · 820 citations · Full text

, , +16

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Hannele Yki‐Järvinen, A. Dressler, M. Ziemen · Diabetes Care · 2000 · 582 citations · Full text

, , +17

Initiating Insulin Therapy in Type 2 Diabetes

Philip Raskin, Elsie Allen, Priscilla Hollander et al. · Diabetes Care · 2005 · 560 citations · Full text

, , +17

Basal Insulin Therapy in Type 2 Diabetes

Julio Rosenstock, Sherwyn Schwartz, Charles M. Clark et al. · Diabetes Care · 2001 · 481 citations · Full text

, , +17